CN1115152C - 用尿苷三磷酸及相关化合物治疗支气管炎的方法 - Google Patents
用尿苷三磷酸及相关化合物治疗支气管炎的方法 Download PDFInfo
- Publication number
- CN1115152C CN1115152C CN97199444A CN97199444A CN1115152C CN 1115152 C CN1115152 C CN 1115152C CN 97199444 A CN97199444 A CN 97199444A CN 97199444 A CN97199444 A CN 97199444A CN 1115152 C CN1115152 C CN 1115152C
- Authority
- CN
- China
- Prior art keywords
- chemical compound
- utp
- bronchus
- bronchioles
- air flue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/744,367 US6159952A (en) | 1996-11-07 | 1996-11-07 | Method of treating bronchitis with uridine triphosphate and related compounds |
US08/744,367 | 1996-11-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1236318A CN1236318A (zh) | 1999-11-24 |
CN1115152C true CN1115152C (zh) | 2003-07-23 |
Family
ID=24992452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97199444A Expired - Lifetime CN1115152C (zh) | 1996-11-07 | 1997-10-21 | 用尿苷三磷酸及相关化合物治疗支气管炎的方法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US6159952A (zh) |
EP (1) | EP0941099B1 (zh) |
JP (1) | JP2001505553A (zh) |
KR (1) | KR100518066B1 (zh) |
CN (1) | CN1115152C (zh) |
AT (1) | ATE249833T1 (zh) |
AU (1) | AU744981B2 (zh) |
BR (1) | BR9714312A (zh) |
CA (1) | CA2271126C (zh) |
DE (1) | DE69724991T2 (zh) |
ES (1) | ES2207723T3 (zh) |
NO (1) | NO992197L (zh) |
NZ (1) | NZ335540A (zh) |
WO (1) | WO1998019685A1 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319908B1 (en) | 1996-07-03 | 2001-11-20 | Inspire Pharmaceuticals, Inc. | Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof |
US5968913A (en) * | 1996-07-03 | 1999-10-19 | Inspire Pharmaceuticals, Inc. | Pharmaceutical compositions of uridine triphosphate |
US5763447C1 (en) | 1996-07-23 | 2002-05-07 | Inspire Pharmaceuticals | Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds |
AU747196B2 (en) | 1997-07-25 | 2002-05-09 | Merck Sharp & Dohme Corp. | Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof |
TW593331B (en) * | 1997-07-25 | 2004-06-21 | Inspire Pharmaceuticals Inc | Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof |
US6872710B2 (en) * | 1997-07-25 | 2005-03-29 | Inspire Pharmaceuticals, Inc. | Di(uridine 5′)-tetraphosphate and salts thereof |
US6251693B1 (en) | 1998-07-30 | 2001-06-26 | Micron Technology, Inc. | Semiconductor processing methods and semiconductor defect detection methods |
WO2000050024A2 (en) * | 1999-02-26 | 2000-08-31 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US6555675B2 (en) | 2000-08-21 | 2003-04-29 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists |
US6867199B2 (en) | 2000-08-21 | 2005-03-15 | Inspire Pharmaceuticals, Inc. | Dinucleoside polyphosphate compositions and their therapeutic use |
US7018985B1 (en) | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7109181B2 (en) | 2001-06-25 | 2006-09-19 | Inspire Pharmaceuticals, Inc. | Joint lubrication with P2Y purinergic receptor agonists |
CN1612739A (zh) * | 2001-11-06 | 2005-05-04 | 印斯拜尔药品股份有限公司 | 治疗或预防炎性疾病的方法 |
MXPA05004121A (es) * | 2002-10-18 | 2006-02-17 | Molichem Medicines Inc | Metodos para tratar la enfermedad de ojo reseco con lantibioticos. |
WO2005107787A1 (en) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
CA2565545A1 (en) * | 2004-05-06 | 2005-12-08 | Molichem Medicines, Inc. | Treatment of ocular diseases and disorders using lantibiotic compositions |
US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
US7851456B2 (en) * | 2005-06-29 | 2010-12-14 | Inspire Pharmaceuticals, Inc. | P2Y6 receptor agonists for treating lung diseases |
US20070249556A1 (en) * | 2006-04-21 | 2007-10-25 | Brubaker Kurt E | Method of treating inflammation |
JP2011026204A (ja) * | 2007-11-26 | 2011-02-10 | Rei Furukawa | タバコの煙を吸入することにより引き起こされる疾患の予防及び/又は治療用組成物 |
WO2019112383A1 (ko) * | 2017-12-08 | 2019-06-13 | 윤주석 | 금속 미네랄 디아미네이트 및 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2122529A1 (de) * | 1971-05-06 | 1972-12-14 | Max Planck Gesellschaft zur Förde rung der Wissenschaften e V , 3400 Gottin gen | Thiophosphatanaloge der Nucleosid di und tnphosphate sowie Verfahren zu ihrer Herstellung |
US3960840A (en) * | 1972-12-29 | 1976-06-01 | University Of Illinois Foundaton | Fluorescent derivatives of adenine-containing compounds |
US4501729A (en) * | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
GB9027968D0 (en) * | 1990-12-22 | 1991-02-13 | Fisons Plc | Method of treatment |
CA2107667A1 (en) * | 1991-04-06 | 1992-10-07 | Anthony Howard Ingall | Atp analogues |
EP0517573A1 (fr) * | 1991-06-05 | 1992-12-09 | Synthelabo | Compositions pharmaceutiques pour le traitement des affections des voies respiratoires |
FR2684299B1 (fr) * | 1991-12-02 | 1995-03-24 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride. |
FR2677250B1 (fr) * | 1991-06-05 | 1995-01-20 | Synthelabo | Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique. |
US5292498A (en) * | 1991-06-19 | 1994-03-08 | The University Of North Carolina At Chapel Hill | Method of treating lung disease with uridine triphosphates |
US5635160A (en) * | 1995-06-07 | 1997-06-03 | The University Of North Carolina At Chapel Hill | Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
US5628984A (en) * | 1995-07-31 | 1997-05-13 | University Of North Carolina At Chapel Hill | Method of detecting lung disease |
-
1996
- 1996-11-07 US US08/744,367 patent/US6159952A/en not_active Expired - Lifetime
-
1997
- 1997-10-21 AU AU49866/97A patent/AU744981B2/en not_active Expired
- 1997-10-21 JP JP52141998A patent/JP2001505553A/ja active Pending
- 1997-10-21 DE DE69724991T patent/DE69724991T2/de not_active Expired - Lifetime
- 1997-10-21 EP EP97912761A patent/EP0941099B1/en not_active Expired - Lifetime
- 1997-10-21 KR KR10-1999-7004018A patent/KR100518066B1/ko not_active IP Right Cessation
- 1997-10-21 CN CN97199444A patent/CN1115152C/zh not_active Expired - Lifetime
- 1997-10-21 NZ NZ335540A patent/NZ335540A/en unknown
- 1997-10-21 CA CA002271126A patent/CA2271126C/en not_active Expired - Lifetime
- 1997-10-21 BR BR9714312-0A patent/BR9714312A/pt not_active Application Discontinuation
- 1997-10-21 WO PCT/US1997/018766 patent/WO1998019685A1/en active IP Right Grant
- 1997-10-21 ES ES97912761T patent/ES2207723T3/es not_active Expired - Lifetime
- 1997-10-21 AT AT97912761T patent/ATE249833T1/de not_active IP Right Cessation
-
1999
- 1999-05-05 NO NO992197A patent/NO992197L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ335540A (en) | 2001-05-25 |
ES2207723T3 (es) | 2004-06-01 |
DE69724991T2 (de) | 2004-11-11 |
NO992197D0 (no) | 1999-05-05 |
WO1998019685A1 (en) | 1998-05-14 |
JP2001505553A (ja) | 2001-04-24 |
AU4986697A (en) | 1998-05-29 |
DE69724991D1 (de) | 2003-10-23 |
CA2271126A1 (en) | 1998-05-14 |
US6159952A (en) | 2000-12-12 |
AU744981B2 (en) | 2002-03-07 |
NO992197L (no) | 1999-07-05 |
EP0941099B1 (en) | 2003-09-17 |
KR100518066B1 (ko) | 2005-09-28 |
CN1236318A (zh) | 1999-11-24 |
EP0941099A1 (en) | 1999-09-15 |
CA2271126C (en) | 2008-04-08 |
ATE249833T1 (de) | 2003-10-15 |
KR20000053094A (ko) | 2000-08-25 |
BR9714312A (pt) | 2000-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1115152C (zh) | 用尿苷三磷酸及相关化合物治疗支气管炎的方法 | |
CN1229114C (zh) | 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法 | |
KR100283306B1 (ko) | 폐질환의검출방법 | |
EP0831777B1 (en) | Dinucleotides useful for the treatment of lung disease | |
EP0938322B1 (en) | Use of uridine triphosphate related compounds for the prevention and treatment of pneumonia in immobilized patients | |
JP2000514461A (ja) | ウリジン・トリホスフェート及び関連化合物による副鼻腔炎の治療方法 | |
CN1143672C (zh) | 含尿苷三磷酸的药物组合物 | |
US5962432A (en) | Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate | |
MXPA99004283A (en) | Method of treating bronchitis with uridine triphosphates and related compounds | |
MXPA00006326A (en) | Novel pharmaceutical compositions of uridine triphosphate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NORTH CAROLINA UNIVERSITY CHAPEL HILL CAMPUS Free format text: FORMER OWNER: INSPIRE PHARMACEUTICALS, INC. Effective date: 20040329 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040329 Address after: North Carolina Patentee after: The University of North Carolina AT Chapel Hill Address before: North Carolina Patentee before: Inspire Pharmaceuticals, INC. |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1022263 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: INSPIRE PHARMACEUTICALS, INC. Free format text: FORMER OWNER: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL Effective date: 20150420 Owner name: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL Effective date: 20150420 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150420 Address after: North Carolina Patentee after: Inspire Pharmaceuticals, INC. Patentee after: The University of North Carolina AT Chapel Hill Address before: North Carolina Patentee before: The University of North Carolina AT Chapel Hill |
|
ASS | Succession or assignment of patent right |
Owner name: MSD CORP. Free format text: FORMER OWNER: INSPIRE PHARMACEUTICALS, INC. Effective date: 20150727 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150727 Address after: new jersey Patentee after: Schering Corporation Patentee after: The University of North Carolina AT Chapel Hill Address before: North Carolina Patentee before: Inspire Pharmaceuticals, INC. Patentee before: The University of North Carolina AT Chapel Hill |
|
CX01 | Expiry of patent term |
Granted publication date: 20030723 |
|
CX01 | Expiry of patent term |